MariMed Inc. (OTCMKTS:MRMD) Short Interest Update

MariMed Inc. (OTCMKTS:MRMD) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totaling 3,327 shares, a drop of 84.0% from the April 30th total of 20,807 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 1,290,557 shares, the days-to-cover ratio is presently 0.0 days.

MariMed Price Performance

Shares of MRMD traded down $0.00 during trading hours on Thursday, hitting $0.07. 407,680 shares of the stock were exchanged, compared to its average volume of 579,422. The stock’s 50-day moving average price is $0.08 and its two-hundred day moving average price is $0.08. MariMed has a 12-month low of $0.06 and a 12-month high of $0.23. The company has a debt-to-equity ratio of 1.67, a quick ratio of 0.34 and a current ratio of 0.95. The company has a market cap of $28.78 million, a price-to-earnings ratio of -2.40 and a beta of 1.33.

MariMed (OTCMKTS:MRMD) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.01) EPS for the quarter, meeting analysts’ consensus estimates of ($0.01). MariMed had a negative net margin of 7.82% and a negative return on equity of 5.00%. The company had revenue of $39.48 million during the quarter, compared to the consensus estimate of $38.75 million. Research analysts expect that MariMed will post -0.04 earnings per share for the current year.

MariMed Company Profile

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.